Nothing Special   »   [go: up one dir, main page]

KR920007995A - 벤즈아미드 유도체 - Google Patents

벤즈아미드 유도체

Info

Publication number
KR920007995A
KR920007995A KR1019910018181A KR910018181A KR920007995A KR 920007995 A KR920007995 A KR 920007995A KR 1019910018181 A KR1019910018181 A KR 1019910018181A KR 910018181 A KR910018181 A KR 910018181A KR 920007995 A KR920007995 A KR 920007995A
Authority
KR
South Korea
Prior art keywords
lower alkyl
general formula
hydrogen atom
benzamide
benzamide derivatives
Prior art date
Application number
KR1019910018181A
Other languages
English (en)
Other versions
KR100209118B1 (ko
Inventor
히로미치 후지와라
아끼히꼬 오가와
히데요 사끼야마
도시아끼 다무라
Original Assignee
시누치 다다미
데이코쿠 케미컬 인더스트리 컴패니 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 시누치 다다미, 데이코쿠 케미컬 인더스트리 컴패니 리미티드 filed Critical 시누치 다다미
Publication of KR920007995A publication Critical patent/KR920007995A/ko
Application granted granted Critical
Publication of KR100209118B1 publication Critical patent/KR100209118B1/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14Nitrogen atoms not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

내용 없음

Description

벤즈아미드 유도체
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (5)

  1. 하기 일반식으로 표현되는 벤즈아미드 유도체 :
    상기식에서, R1은 수소원자, 저급알킬, 할로겐 치환 저급알킬 또는 아랄킬기이고; R2는 수소원자 또는 저급 알킬기이다.
  2. 하기 일반식으로 표현되는 벤즈아미드 유도체 :
  3. 히기 일반식으로 표현되는 (2'S,4'S)-벤즈아미드 유도체 :
  4. 하기 일반식의 벤즈아미드 유도체 또는 이것의 산부가염 및 약제학적으로 수용할 수 있는 담체를 포함하는 약제 조성물 :
    상기식에서, R1은 수소원자, 저급알킬, 할로겐 치환된 저급알킬 또는 아랄킬기이고; R2는 수소원자 또는 저급알킬기이다.
  5. 위장관의 활성을 촉진시키기 위한 제제로서 제4항의 약제조성물의 용도.
    ※ 참고사항 : 최초출원 내용에 의하여 공개되는 것임.
KR1019910018181A 1990-10-16 1991-10-16 벤즈아미드 유도체 KR100209118B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP277976/90 1990-10-16
JP27797690 1990-10-16

Publications (2)

Publication Number Publication Date
KR920007995A true KR920007995A (ko) 1992-05-27
KR100209118B1 KR100209118B1 (ko) 1999-07-15

Family

ID=17590893

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019910018181A KR100209118B1 (ko) 1990-10-16 1991-10-16 벤즈아미드 유도체

Country Status (9)

Country Link
US (1) US5143935A (ko)
EP (1) EP0481756B1 (ko)
JP (1) JP2529912B2 (ko)
KR (1) KR100209118B1 (ko)
AT (1) ATE155127T1 (ko)
DE (1) DE69126758T2 (ko)
DK (1) DK0481756T3 (ko)
ES (1) ES2106058T3 (ko)
TW (1) TW228520B (ko)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7665694A (en) * 1993-09-21 1995-04-10 Yamanouchi Pharmaceutical Co., Ltd. N-(3-pyrrolidinyl)benzamide derivative
KR100333501B1 (ko) * 2000-01-19 2002-04-25 박호군 벤즈아미드 화합물 및 그 제조방법
EP1547593A4 (en) * 2002-09-12 2009-12-23 Nagase Chemtex Corp MEDICINAL COMPOSITION
JP4760139B2 (ja) * 2004-05-28 2011-08-31 田辺三菱製薬株式会社 ピロリジン誘導体およびその製法
TW200602314A (en) * 2004-05-28 2006-01-16 Tanabe Seiyaku Co A novel pyrrolidine compound and a process for preparing the same
KR100881040B1 (ko) * 2005-03-11 2009-02-05 나가세케무텍쿠스가부시키가이샤 의약 조성물
JP4943826B2 (ja) * 2005-11-25 2012-05-30 田辺三菱製薬株式会社 医薬組成物
JP2010031063A (ja) * 2009-11-18 2010-02-12 Nagase Chemtex Corp 医薬組成物
TWI808055B (zh) 2016-05-11 2023-07-11 美商滬亞生物國際有限公司 Hdac 抑制劑與 pd-1 抑制劑之組合治療
TWI794171B (zh) 2016-05-11 2023-03-01 美商滬亞生物國際有限公司 Hdac抑制劑與pd-l1抑制劑之組合治療
WO2024077078A2 (en) * 2022-10-05 2024-04-11 The Research Foundation For The State University Of New York Sterylglucosidase inhibiting compositions and method of using

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1593146A (en) * 1976-11-05 1981-07-15 Beecham Group Ltd Octahydro-quinolizinyl benzamide derivatives
US4143150A (en) * 1977-08-19 1979-03-06 A. H. Robins Company, Inc. Derivatives of oxanilic acid
DE2855853C2 (de) * 1978-12-22 1986-09-11 Yamanouchi Pharmaceutical Co., Ltd., Tokio/Tokyo N-(1-Benzyl-2-methyl-3-pyrrolidinyl)-5-chlor-2-methoxy-4-methylaminobenzamid dessen Säureadditionssalze, Verfahren zu deren Herstellung und ihre Verwendung
GB8718346D0 (en) * 1987-08-03 1987-09-09 Fordonal Sa Substituted benzamides
IT1216120B (it) * 1988-03-17 1990-02-22 Poli Ind Chimica Spa Derivati n_cicloalchilaminoetilbenzamidici, loro preparazione e composizioni farmaceutiche che li contengono.

Also Published As

Publication number Publication date
KR100209118B1 (ko) 1999-07-15
DK0481756T3 (da) 1998-02-16
US5143935A (en) 1992-09-01
JP2529912B2 (ja) 1996-09-04
EP0481756B1 (en) 1997-07-09
JPH0517434A (ja) 1993-01-26
EP0481756A2 (en) 1992-04-22
ATE155127T1 (de) 1997-07-15
ES2106058T3 (es) 1997-11-01
DE69126758T2 (de) 1998-02-12
TW228520B (ko) 1994-08-21
DE69126758D1 (de) 1997-08-14
EP0481756A3 (en) 1992-08-26

Similar Documents

Publication Publication Date Title
KR920018029A (ko) 신규한 카복실산 아미드
ES2124545T3 (es) Azolidindionas como agentes antihiperglucemicos.
KR890008150A (ko) 퀴놀린 카르본산 유도체
KR960007592A (ko) 신규한 피롤로카바졸
KR920007995A (ko) 벤즈아미드 유도체
KR890011596A (ko) 불면증 치료용 의약품의 제조에 있어서 1,4-이치환-피페리디닐 화합물의 용도
KR900003163A (ko) 시클로헥산 유도체
KR900006347A (ko) 살균성 플루오로퀴놀로닐 세펨
KR930016402A (ko) 항-hiv 활성을 갖는 이미다졸 유도체
ATE86860T1 (de) Praeparat gegen ulcus.
KR890003752A (ko) 2-피리미디닐-피페라딘 유도체의 용도
KR910009266A (ko) 수의학 약제로서 유용한 피리돈-카르복실산 유도체
KR900001673A (ko) N-치환 아미드 유도체
KR920000715A (ko) 신규의 n- 벤질-n1- 페닐-및- 펜알킬- 티오우레아류
KR890008148A (ko) 새로운 세파로스포린 화합물 및 항균제
KR850002477A (ko) 4-(3-알키닐옥시-2-하이드록시-프로필)-피퍼라진-1-일-n-페닐-아세트아미드 유도체의 제조방법
KR930021629A (ko) 피페라진 유도체
KR930702339A (ko) 에폭시숙시남산 유도체
KR940018351A (ko) 노나테트라에노산 유도체
KR850002478A (ko) 2-(n-피롤리디노)-3-이소부톡시-n-치환된 페닐-n-벤질-프로필아민의 제조방법
ATE43594T1 (de) 3-alkoxy-2-(n-pyrrolidino)-n-pyridyl-n-furyl(od r thienyl)-methyl-propylamine, ihre herstellung und diese enthaltende pharmazeutische mittel.
KR900700104A (ko) 항불안제
KR840006810A (ko) 세팔로스포린 에스테르의 제조방법
KR890008151A (ko) 키놀린 카르복산의 유도체
KR930005621A (ko) 고혈압 치료용 제약 조성물

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20090403

Year of fee payment: 11

LAPS Lapse due to unpaid annual fee